Atul Pande - 01 Nov 2021 Form 4 Insider Report for Karuna Therapeutics, Inc.

Role: Director
Signature: /s/ Troy Ignelzi, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 01 Nov 2021
Net transactions value: -$301,675
Form type: 4
Filing time: 03 Nov 2021, 16:14:06 UTC
Previous filing: 01 Oct 2021
Next filing: 02 Dec 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	KRTX	Common Stock	Options Exercise	$40,000	+2,500		$16.00^*	2,500	01 Nov 2021	Direct
transaction	KRTX	Common Stock	Sale	$341,675	-2,500	-100%	$136.67	0	01 Nov 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	KRTX	Option (right to buy)	Options Exercise	$0	-2,500	-25%	$0.000000	7,500	01 Nov 2021	Common Stock	2,500	$16.00	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 1, 2021.